Kite Pharma (KITE) Tops Q2 EPS by 30c

August 8, 2016 4:28 PM EDT
Get Alerts KITE Hot Sheet
Trade KITE Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Kite Pharma (NASDAQ: KITE) reported Q2 EPS of ($0.91), $0.30 better than the analyst estimate of ($1.21). Revenue for the quarter came in at $4.8 million versus the consensus estimate of $4.86 million.

For earnings history and earnings-related data on Kite Pharma (KITE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment